1 completed, 1 not yet recruiting. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Tolterodine 4 mg: new trials by email Literature Review of Tolterodine 4 mg trials Research Report on Tolterodine 4 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial Mirabegron 25mg, Solifenacin 5 mg, Tolterodine 4 mg - Urinary Bladder, Overactive | Phase 3 | Not yet recruiting | Far Eastern Memorial Hospital | 220 | 2025-08-07 | 2025-08-11 |
| Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor Overactivity Tolterodine 4 mg, arm 2: Tolterodine 4 mg + local oestrogens once daily for 12 weeks - Overactive Bladder | Phase 2 / Phase 3 | Completed | Università degli Studi dell'Insubria | 2004-01-01 | 2008-04-01 |
Urinary Bladder, Overactive (2) · Nocturia (1)
Far Eastern Memorial Hospital (1) · Università degli Studi dell'Insubria (1)
Italy (1) · Taiwan (1)